KKR Stockholders Approve Board Authority, Fail to Remove Supermajority Vote for Charter Amendments; Meeting Adjourned for Re-Vote
Summary
KKR & Co. Inc. stockholders approved amendments granting the Board more power but failed to pass a proposal to remove supermajority voting requirements for charter changes, leading to an adjourned meeting for re-vote.
Key Events
-
Supermajority Vote Removal Fails
Proposal 1, an amendment to remove the supermajority voting requirement for stockholders to amend certain charter provisions, failed to pass with 85.97% 'For' votes, falling short of the required 90%.
-
Special Meeting Adjourned
The special meeting was adjourned until May 21, 2026, specifically for Proposal 1, to allow for additional time to solicit proxies and secure the necessary votes.
-
Board Gains Authority to Fill Vacancies
Proposal 3, granting the Board the sole authority to fill board vacancies and newly created directorships, was approved by stockholders with 71.82% 'For' votes.
-
Stockholders' Meetings as Sole Approval Mechanism Approved
Proposal 2, establishing stockholders' meetings as the sole mechanism for approval of matters requiring a common stock vote, was approved with 59.03% 'For' votes.
Analysis
KKR & Co. Inc. held a special meeting where stockholders approved several amendments to the company's charter, including granting the Board sole authority to fill vacancies and fixing the Board's size. However, a key proposal to eliminate the supermajority voting requirement for certain charter amendments failed to pass, receiving 85.97% support against a 90% threshold. This indicates significant shareholder resistance to a measure that would simplify future governance changes. The meeting has been adjourned until May 21, 2026, to allow for additional proxy solicitation on this specific proposal, highlighting its importance to management and the ongoing shareholder debate.
At the time of this filing, KKR was trading at $100.43 on NYSE in the Finance sector, with a market capitalization of approximately $90.8B. The 52-week trading range was $82.67 to $153.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.